Warfarin-Induced Skin Necrosis with Underlying Protein C/S Deficiency
The most likely cause of extensive thigh skin necrosis in this patient on day 5 of hospitalization for pulmonary embolism is warfarin administration, particularly if the patient has an underlying protein C or S deficiency (Answer D: A combination of A and B).
Clinical Reasoning
The timing is the critical diagnostic clue here. According to the American College of Chest Physicians guidelines, warfarin-induced skin necrosis typically occurs on days 3-8 of therapy and results from extensive thrombosis of venules and capillaries within subcutaneous fat 1. This patient's presentation on day 5 fits this classic timeframe perfectly.
Why Warfarin + Protein C/S Deficiency?
The pathophysiology involves warfarin's differential effect on coagulation factors:
- Protein C has the shortest half-life (6-8 hours) among vitamin K-dependent factors
- Warfarin causes a rapid drop in protein C levels before reducing procoagulant factors II, IX, and X
- This creates a transient hypercoagulable state in the first few days of therapy
- The thigh area is a classic location for this complication
While protein C deficiency is strongly associated with warfarin-induced skin necrosis, the guidelines explicitly state this complication also occurs in non-deficient individuals 1. The underlying deficiency increases risk but is not absolutely required.
Why Not Heparin Alone?
The FDA drug label for heparin does mention skin necrosis, but specifically notes it occurs at the site of subcutaneous injection and may require skin grafting 2. The extensive thigh involvement described here is not consistent with injection site reactions. Additionally, heparin-associated skin necrosis would have appeared earlier in the hospitalization course.
Critical Caveat About HIT
One important exception exists: Warfarin can cause venous limb gangrene when started in patients with heparin-induced thrombocytopenia (HIT) after heparin withdrawal 1. A case series documented catastrophic multicentric skin necrosis in patients with HIT who received warfarin 3. However, the question doesn't provide platelet counts or suggest HIT, making the classic warfarin-induced skin necrosis with possible protein C/S deficiency the most likely diagnosis.
Management Implications
Warfarin must be immediately discontinued 1. The guidelines state that warfarin therapy is contraindicated after skin necrosis develops.
If this patient requires ongoing anticoagulation:
- Switch to parenteral anticoagulation (therapeutic heparin or LMWH)
- If warfarin must eventually be restarted, use a low-dose initiation (2 mg) under coverage of therapeutic parenteral anticoagulation
- Gradually titrate up over 1 or more weeks to avoid abrupt protein C depletion
- Consider direct oral anticoagulants as an alternative, though rare skin necrosis has been reported with apixaban 4
Answer: D (A combination of A and B)
The combination of warfarin administration during the vulnerable early treatment period, potentially unmasking or exacerbated by underlying protein C or S deficiency, best explains this clinical presentation.